Meanwhile, when RPT is directed at cells in the surrounding TME instead of directly targeting cancer cells, such as through FAP targeting, both 177Lu and 225Ac may exhibit reduced effectiveness in cancer cell-enriched areas. Here, FAP is linked to cancer.